Top 20 Health Care VC Funds & Investors in Iceland (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
New Business Venture Fund
VC Fund
|
10 | Iceland, United States, China | Seed, Series A | Software, Health Care, Medical | $400k–$3.4M |
|
Frumtak Ventures
VC Fund
|
4 | Iceland, Estonia, United States | Seed, Series A | Software, Information Technology, SaaS | $974k–$20M |
|
Novator
VC Fund
|
3 | United Kingdom, United States, Iceland | Series B, Series C | Software, E-Commerce, Online Games | $16M–$450M |
|
Brunnur Ventures
VC Fund
|
3 | Iceland, United States, Denmark | Seed, Series A | Software, SaaS, Gaming | $1M–$16M |
|
Crowberry Capital
VC Fund
|
2 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $1k–$17M |
|
Silfurberg
VC Fund
|
2 | Iceland | Seed, Series A | Biotechnology, Medical, Health Care | |
|
Kvika Asset Management
VC Fund
|
2 | Iceland | Series A | Medical, Health Care, Biotechnology | |
|
Iceland Venture Studio
VC Fund
|
2 | Iceland, India, Israel | Seed, Pre-Seed | Software, Health Care, B2B | $500k–$3M |
|
ABC Ventures
VC Fund
|
1 | India, Iceland | Pre-Seed, Series A | Water, Medical, Health Care | |
|
Probiocon
VC Fund
|
1 | Iceland | Seed | Medical, Consulting, Health Care | |
|
Wellington Partners
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$55M |
|
Baliopharm
VC Fund
|
1 | Iceland | Seed | Medical, Consulting, Health Care | |
|
Silicon Valley Bank
VC Fund
|
1 | United States, United Kingdom, Canada | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $3M–$130M |
|
Omega ehf
VC Fund
|
1 | Iceland, United Kingdom | Seed, Series A, Series D | Software, Banking, FinTech | |
|
Asabys Partners
VC Fund
|
1 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$135M |
|
Angels
VC Fund
|
1 | United Kingdom, India, Brazil | Pre-Seed, Seed | Software, Artificial Intelligence, SaaS | $299k–$1.2M |
|
Flerie Invest
VC Fund
|
1 | Sweden, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Pharmaceutical | $2.5M–$75M |
|
BioInnovation Institute
VC Fund
|
1 | Denmark, Germany, Switzerland | Convertible Note, Pre-Seed, Debt Financing | Biotechnology, Medical, Health Care | $500k–$5.2M |
|
Yanu Holdings
VC Fund
|
1 | Iceland | Health Care, Biotechnology, Medical Device | ||
|
Dr. Agon
VC Fund
|
1 | Iceland | Seed | Pharmaceutical | |
| Access all 52 VC funds in Iceland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The New Business Venture Fund is an evergreen investment fund that actively contributes to the development and growth of the Icelandic economy by investing in promising innovation and start-up companies.The New Business Venture Fund invests at seed and early stage in promising growth companies with great business ideas and strong management anddevelopment teams.The New Business Venture Fund is a state owned investment fund intended to strengthen and develop the Icelandic venture capital market along with promoting startups and business in Iceland thus encouraging economic growth.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Iceland, United States, China
Investor stats
- Total investments: 40
- Round size: Seed $400k–$2.6M; Series A $450k–$3.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Sundra — Sundra is a translation software that helps HR teams translate their learning content so every employee feels included.
- HorseDay — HorseDay is a mobile application to track horse activities.
- Arcana Bio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness
At Frumtak Ventures, we champion founders who have demonstrated early traction and have potential to become global leaders in their space. We take a concentrated, high-conviction, and high-involvement approach to investing and dedicate ourselves to collaboratively work with our portfolio companies from the seed stage through IPO. Our initialticket size usually ranges from €1 million to €3 million.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Iceland, Estonia, United States
Investor stats
- Total investments: 40
- Round size: Seed $974k–$4.7M; Series A $1.2M–$20M
- Lead/follow: 73% lead, 27% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Optise — Optise is an AI-powered website insights tool for B2B businesses.
- MyDello — Get instant quotes for all transportation modes. Enter a new era of freight forwarding with the MyDello logistics platform. Sign up for free
- Euler —
Novator is an alternative investment firm founded and led by the international investor and entrepreneur Thor Bjorgolfsson.Novator's investment portfolio is focused around following sectors: Telecommunications, Pharmaceuticals, IT and Renewable Energy. In addition, Novator operates a Private Equity Fund and a Credit Opportunities Fund.Novator focuses on developing strong management teams in each of its portfolio companies. While granting them the autonomy to create value, Novator maintains a supervisory role, principally through representation on the Boards of its investee companies. Novator differentiates itself from many other private equity companies in concentrating on complex situations, either by virtue of their structure or their cross-border nature. To create value, Novator undertakes the restructuring or "de-risking" of investment opportunities through re-financing, combining acquired assets with existing businesses, through sale to strategic or financial buyers, or through flotation. Novator's investment portfolio is focused around four main sectors:Telecommunications, Pharmaceuticals, IT and Renewable Energy.
Show more...Investment focus
- Industry: Software, E-Commerce, Online Games
- Stage:Series B, Series C
- Geography: United Kingdom, United States, Iceland
Investor stats
- Total investments: 59
- Round size: Series B $16M–$125M; Series C $16M–$450M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Numan — Convenient care, tailored to you. Offering treatments for weight loss, diagnostics, erectile dysfunction, hair loss, and more.
- Nord Security — Nord Security is the leader in the field of online privacy and security. Our security tools have earned praise from respected experts and tech outlets.
- Steel City Interactive — Steel City Interactive develops gaming.
Brunnur Ventures is a top venture capital firm in Iceland for startups with high-growth potential.
Show more...Investment focus
- Industry: Software, SaaS, Gaming
- Stage:Seed, Series A
- Geography: Iceland, United States, Denmark
Investor stats
- Total investments: 32
- Round size: Seed $1M–$5.3M; Series A $1.5M–$16M
- Lead/follow: 66% lead, 34% follow
- Last fund: May invest from a new fund soon — raised $65M in 2021
Portfolio highlights
- Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
- AviLabs — AviLabs specializes in software development in aviation.
- Ghostlamp — Ghostlamp enables brands and agencies to create on-demand micro influencer campaigns, anywhere in the world via the use of an online self-serve platform.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 49
- Round size: Seed $1.6M–$4.2M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Augmented Hearing — Augmented Hearing is creating game-changing technology that will be used in fields such as voice assistants, hearing health, environmental noise suppression in phone calls, and many more.
Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies. The firm follows up its investments as an active participant in the company and aims all the time to add value to its investments whenever possible. Silfurberg was founded in 2002 and is based in Reykjavík,Iceland.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Iceland
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
- Oculis — Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.
Kvika Asset Management manages a broad range of funds including equity funds, bond funds and mixed funds.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Iceland
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PLAIO — PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
- EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
We help people grow and build decentralized companies
Show more...Investment focus
- Industry: Software, Health Care, B2B
- Stage:Seed, Pre-Seed
- Geography: Iceland, India, Israel
Investor stats
- Total investments: 13
- Round size: Seed $500k–$3M; Pre-Seed $950k–$1M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $5M in 2019
Portfolio highlights
- Soptle — Founded in Sep 2021, Soptle started to establish an integrated technology to the neglected regional FMCG Manufacturers in India with a B2B Retail Commmerce App. It uses tech and data to distribute at scale and use necessary components (existing Distributor/Wholesaler) in the FMCG Supply Chain to build a high growth and profitable business.
- Sundra — Sundra is a translation software that helps HR teams translate their learning content so every employee feels included.
- Expertrons — Expertrons is an upskilling platform that offers advanced training programs | BSFI | HR | Marketing and many more to assure 100% professional success.
ABC Ventures operates as an investment firm.
Show more...Investment focus
- Industry: Water, Medical, Health Care
- Stage:Pre-Seed, Series A
- Geography: India, Iceland
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Polka Pop — Polka Pop is India's first brand to serve naturally flavored sparkling water with zero calories and no added sugar. Supporting a sustainable lifestyle choice, this healthy drink is available in four flavors, i.e. lemon-lime, orange, peach, and cranberry. The fizz makes this the best mix for cocktails and mocktails.
- EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
Probiocon is a consulting company offering comprehensive services for pharmaceutical and biotechnological companies. We give advice and support for all kind of corporate development activities (services) needed for biotech and pharma companies, including but not limited to Corporate Financing, Licensing & Partnering, Merger & Acquisition,and Corporate Organisation.Their vision is to provide optimized and cost-effective solutions to the special needs of companies developing biopharmaceutical compounds.
Show more...Investment focus
- Industry: Medical, Consulting, Health Care
- Stage:Seed
- Geography: Iceland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Series A $3.1M–$33M; Series B $7.7M–$55M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient. The company was founded in 2020 and is based in Thousand Oaks, CA.
Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.
Show more...Investment focus
- Industry: Medical, Consulting, Health Care
- Stage:Seed
- Geography: Iceland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 462
- Round size: Series A $5M–$30M; Series B $6M–$45M; Debt Financing $3M–$130M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- ShipBob — Ecommerce fulfillment for online stores. ShipBob empowers businesses to offer 2-day shipping and manage inventory, orders, and shipments.
- SunVest Solar — SunVest Solar is a solar development company that assists commercial building owners, non-profit organisations, tribes, and landowners in investing in sustainable solar energy. We help our customers become more sustainable while reducing their carbon footprint.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Omega ehf is a private investment vehicle that makes investments in private equity and a variety of ventures.
Show more...Investment focus
- Industry: Software, Banking, FinTech
- Stage:Seed, Series A, Series D
- Geography: Iceland, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
- Meniga — Meniga helps banks use data to drive Digital Engagement, build Customer Loyalty & increase Revenue.
- Treble — We develop next generation sound simulation and spatial audio technology for digital twins and virtual worlds.
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Angels
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, India, Brazil
Investor stats
- Total investments: 7
- Round size: Seed $413k–$1M; Pre-Seed $299k–$1.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RumiTech — RumiTech is an initiative that transforms street lighting poles into a grid-independent, next-generation energy and communication infrastructure.
- Arcana Bio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness
- Movens — Movens is a revenue-based financing platform for e-commerce brands. We deeply understand the business to support entrepreneurs in their growth journey, solving working capital issues and cash flow fluctuations with affordable, flexible funding and insights with data intelligence.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 22
- Round size: Series A $2.5M–$21M; Series B $12M–$75M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Convertible Note, Pre-Seed, Debt Financing
- Geography: Denmark, Germany, Switzerland
Investor stats
- Total investments: 87
- Round size: Pre-Seed $516k–$5.2M; Debt Financing $533k–$1.4M; Convertible Note $500k–$1.5M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Yanu Holdings is a global investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Geography: Iceland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Genis — Genis is pioneering the development and application of therapeutic chitin derivatives.
Dr. Agon
Show more...Investment focus
- Industry: Pharmaceutical
- Stage:Seed
- Geography: Iceland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PLAIO — PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
Health Care VC funding in Iceland at a glance
Stats across 73 deals from 52 investors.
Access all 52 VC funds in Iceland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Iceland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 52 VC funds investing in Iceland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!